Parse Biosciences Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
133
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$225M
Parse Biosciences General Information
Description
Developer of a single-cell sequencing technology designed to perform experiments without the need for custom instrumentation. The company offers a platform that analyzes single-nucleus transcriptomes and captures early postnatal development in the murine central nervous system, enabling researchers to increase gene detection in individual cells while reducing confounding artifacts common in single-cell sequencing experiments.
Contact Information
Website
www.parsebiosciences.com(Operating Subsidiary)
Corporate Office
- 700 Dexter Avenue
- Suite 600
- Seattle, WA 98109
- United States
Corporate Office
- 700 Dexter Avenue
- Suite 600
- Seattle, WA 98109
- United States
Parse Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 01-Dec-2025 | $225M | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series C) | 14-Dec-2023 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series B) | 15-Feb-2022 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 26-Jan-2021 | Completed | Generating Revenue | |||
| 4. Grant | 02-Jul-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 12-Oct-2018 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. University Spin-Out | 01-Jan-2018 | Completed | Generating Revenue |
Parse Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 1,075,832 | $0.000100 | $1.26 | $1.26 | 1x | $1.26 | 5.78% | |
| Series A-1 | 2,916,519 | $0.000100 | $2.37 | $2.37 | 1x | $2.37 | 15.67% |
Parse Biosciences Comparisons
Industry
Financing
Details
Parse Biosciences Competitors (31)
One of Parse Biosciences’s 31 competitors is Arbor Biotechnologies, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arbor Biotechnologies | Venture Capital-Backed | Cambridge, MA | ||||
| GnuBIO | Formerly VC-backed | Cambridge, MA | ||||
| Standard BioTools | Formerly VC-backed | Boston, MA | ||||
| Asuragen | Formerly VC-backed | Austin, TX | ||||
| Vizgen | Venture Capital-Backed | Cambridge, MA |
Parse Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Parse Biosciences Patents
Parse Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025179223-A1 | New methods and kits for combinatorial labeling of cellular molecules | Pending | 21-Feb-2024 | ||
| WO-2025137724-A2 | Methods and kits for single-cell transcriptome analysis and immune profiling | Inactive | 22-Dec-2023 | ||
| WO-2025137724-A3 | Methods and kits for single-cell transcriptome analysis and immune profiling | Inactive | 22-Dec-2023 | ||
| EP-4662310-A2 | Methods and kits for labeling cellular molecules for multiplex analysis | Pending | 07-Feb-2023 | ||
| WO-2024168092-A2 | Methods and kits for labeling cellular molecules for multiplex analysis | Inactive | 07-Feb-2023 | C12Q1/6806 |
Parse Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Parse Biosciences Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Janus Henderson Investors | Asset Manager | Minority | ||
| Logos Capital | Hedge Fund | Minority | ||
| Marshall Wace | Hedge Fund | Minority | ||
| Planetary Technologies | Venture Capital | Minority | ||
| Sahsen Ventures | Venture Capital | Minority |
Parse Biosciences Acquisitions (1)
Parse Biosciences’s most recent deal was a Merger/Acquisition with Biomage. The deal was made on 16-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Biomage | 16-Jan-2024 | Merger/Acquisition | Discovery Tools (Healthcare) |
Parse Biosciences Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Biomage | Edinburgh, United Kingdom | 2019 |
Parse Biosciences FAQs
-
When was Parse Biosciences founded?
Parse Biosciences was founded in 2018.
-
Where is Parse Biosciences headquartered?
Parse Biosciences is headquartered in Seattle, WA.
-
What is the size of Parse Biosciences?
Parse Biosciences has 133 total employees.
-
What industry is Parse Biosciences in?
Parse Biosciences’s primary industry is Discovery Tools (Healthcare).
-
Is Parse Biosciences a private or public company?
Parse Biosciences is a Private company.
-
What is the current valuation of Parse Biosciences?
The current valuation of Parse Biosciences is .
-
What is Parse Biosciences’s current revenue?
The current revenue for Parse Biosciences is .
-
How much funding has Parse Biosciences raised over time?
Parse Biosciences has raised $100M.
-
Who are Parse Biosciences’s investors?
Janus Henderson Investors, Logos Capital, Marshall Wace, Planetary Technologies, and Sahsen Ventures are 5 of 10 investors who have invested in Parse Biosciences.
-
Who are Parse Biosciences’s competitors?
Arbor Biotechnologies, GnuBIO, Standard BioTools, Asuragen, and Vizgen are some of the 31 competitors of Parse Biosciences.
-
When was Parse Biosciences acquired?
Parse Biosciences was acquired on 01-Dec-2025.
-
Who acquired Parse Biosciences?
Parse Biosciences was acquired by Qiagen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
